Related Experiment Video
Updated: Jun 3, 2026
05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
[Comparative study of somatic oncogene mutations in normal thyroid tissues and thyroid neoplasms].
Bálint Tóbiás1, Bernadett Balla, János Kósa P
1Semmelweis Egyetem, Általános Orvostudományi Kar I. Belgyógyászati Klinika Budapest Korányi S. u. 2/A 1083. tobiasb@bell.sote.hu
Orvosi Hetilap
|April 6, 2011
Summary
Thyroid cancer development is linked to specific gene mutations like BRAF and NRAS, and translocations such as RET/PTC. Genetic analysis of thyroid tissue samples confirmed these associations, aiding in malignancy diagnosis and prognosis.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Thyroid cancer development is associated with various somatic oncogene mutations (e.g., BRAF, NRAS, HRAS, KRAS) and gene translocations (e.g., RET/PTC, PAX8/PPAR-gamma).
- Understanding these genetic alterations is crucial for diagnosing and understanding the progression of thyroid malignancies.
Purpose of the Study:
- To investigate the presence of specific oncogene mutations and gene translocations in intraoperative thyroid tissue samples.
- To correlate genetic findings with pathological diagnoses of thyroid cancer.
- To evaluate the potential of genetic data in supporting thyroid cancer diagnosis and prognosis.
Main Methods:
- Analysis of 22 intraoperative thyroid tissue samples (11 pathologic, 11 normal).
- Somatic single nucleotide polymorphisms (SNPs) analyzed using the LightCycler melting method.
- Gene translocations identified via real-time polymerase chain reaction (PCR).
Main Results:
- Identified three BRAF, two NRAS, and one HRAS mutation in tumorous samples.
- Detected one RET/PTC1 translocation in a tumorous sample.
- Results align with international data linking these genetic alterations to thyroid cancer.
Conclusions:
- Confirmed the association between specific oncogene mutations/translocations and thyroid cancer.
- Genetic data, combined with cytological examination, can enhance the diagnosis of thyroid malignancies.
- Identified genetic alterations may serve as indicators of malignant transformation and potential prognostic factors.
Related Concept Videos
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...